Home / Companies / Aurobindo Pharma Limited / 10 Sep 2025
Aurobindo Pharma Limited: meeting of 10 Sep 2025
Votes reported on Form N-PX, item by item
57 Form N-PX filers reported votes at the Aurobindo Pharma Limited meeting of 10 Sep 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 56.6% of reported votes for; 49 filers withheld from or voted against at least one nominee.
198 vote records from 57 filers. 2 of the 57 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
99 vote records from 57 filers. 1 of the 57 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
184 vote records from 50 filers. 0 of the 50 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
14 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | Split or no vote | For |
| BlackRock and iShares | Split or no vote | For |
| Fidelity | Split or no vote | For |
| Dimensional | Split or no vote | For |
| State Street and SPDR | For | For |
| American Century | Split or no vote | For |
| Franklin Templeton | Split or no vote | For |
| Invesco | Split or no vote | For |
| Equitable | For | Abstain or withhold * |
| Charles Schwab | Split or no vote | For |
| Nuveen and TIAA | Split or no vote | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Against * | For |
| J.P. Morgan | Split or no vote | For |
| Goldman Sachs | For | For |
| WisdomTree | Split or no vote | For |
| Jackson National funds | Split or no vote | For |
| Northern Trust and FlexShares | Split or no vote | For |
| Lincoln Financial | For | For |
| Voya | Split or no vote | For |
| Russell Investments | Split or no vote | For |
| Brighthouse Funds | For | For |
| Columbia Threadneedle | For | For |
| BNY Mellon | Split or no vote | For |
| Pacific Life funds | Split or no vote | For |
| Macquarie and Delaware Funds | Split or no vote | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Aurobindo Pharma Limited meeting?
57 Form N-PX filers reported votes at the meeting of 10 Sep 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Aurobindo Pharma Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Aurobindo Pharma Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Aurobindo Pharma Limited with a meeting date within three days of 10 Sep 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.